HEADER HYDROLASE 25-OCT-01 1K8Q TITLE CRYSTAL STRUCTURE OF DOG GASTRIC LIPASE IN COMPLEX WITH A PHOSPHONATE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIACYLGLYCEROL LIPASE, GASTRIC; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.1.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: LIPF; SOURCE 7 EXPRESSION_SYSTEM: ZEA MAYS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4577; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HI-II MAIZE GERMPLASM; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PUC18 KEYWDS APHA BETA HYDROLASE FOLD, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.ROUSSEL,N.MILED,L.BERTI-DUPUIS,M.RIVIERE,S.SPINELLI,P.BERNA, AUTHOR 2 V.GRUBER,R.VERGER,C.CAMBILLAU REVDAT 6 16-AUG-23 1K8Q 1 HETSYN REVDAT 5 29-JUL-20 1K8Q 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 13-JUL-11 1K8Q 1 VERSN REVDAT 3 24-FEB-09 1K8Q 1 VERSN REVDAT 2 20-MAR-02 1K8Q 3 ATOM LINK HET REMARK REVDAT 1 06-MAR-02 1K8Q 0 JRNL AUTH A.ROUSSEL,N.MILED,L.BERTI-DUPUIS,M.RIVIERE,S.SPINELLI, JRNL AUTH 2 P.BERNA,V.GRUBER,R.VERGER,C.CAMBILLAU JRNL TITL CRYSTAL STRUCTURE OF THE OPEN FORM OF DOG GASTRIC LIPASE IN JRNL TITL 2 COMPLEX WITH A PHOSPHONATE INHIBITOR. JRNL REF J.BIOL.CHEM. V. 277 2266 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11689574 JRNL DOI 10.1074/JBC.M109484200 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 24389 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1174 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6064 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 188 REMARK 3 SOLVENT ATOMS : 382 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1K8Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-01. REMARK 100 THE DEPOSITION ID IS D_1000014700. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24343 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.21500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1HLG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30 % PEGMME 2000, 0.1 M SODIUM ACETATE REMARK 280 AND 0.2 M AMMONIUM SULFATE, PH 4.6, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.57800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.57800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 30.60450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 82.24900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 30.60450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 82.24900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 88.57800 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 30.60450 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 82.24900 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 88.57800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 30.60450 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 82.24900 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2003 O HOH B 2140 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 54 40.71 30.65 REMARK 500 ALA A 69 -167.61 -120.49 REMARK 500 ASN A 77 -126.00 -123.19 REMARK 500 ASN A 81 20.44 -140.63 REMARK 500 ALA A 105 46.23 -144.75 REMARK 500 ARG A 106 51.68 -115.21 REMARK 500 SER A 153 -123.73 61.22 REMARK 500 PHE A 163 -6.84 -57.45 REMARK 500 ILE A 192 2.81 -63.35 REMARK 500 LYS A 210 -130.60 -119.35 REMARK 500 TYR A 213 70.54 33.04 REMARK 500 ASP A 247 58.28 -160.02 REMARK 500 SER A 291 140.04 167.13 REMARK 500 LEU A 326 -62.09 -101.22 REMARK 500 VAL A 366 -56.75 -134.18 REMARK 500 THR A 376 42.06 -102.18 REMARK 500 ASN B 54 35.99 34.69 REMARK 500 ASN B 77 -127.98 -129.67 REMARK 500 ALA B 105 49.78 -144.41 REMARK 500 SER B 153 -125.96 61.67 REMARK 500 PHE B 163 -4.85 -55.52 REMARK 500 ILE B 192 3.33 -59.45 REMARK 500 LYS B 210 -129.11 -116.56 REMARK 500 TYR B 213 69.38 33.42 REMARK 500 ASP B 247 55.97 -154.55 REMARK 500 SER B 291 140.39 164.35 REMARK 500 LEU B 326 -60.59 -104.57 REMARK 500 ALA B 327 59.69 -92.99 REMARK 500 VAL B 366 -56.48 -136.85 REMARK 500 THR B 376 39.27 -98.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HLG RELATED DB: PDB REMARK 900 1HLG CONTAINS HUMAN GASTRIC LIPASE WITHOUT INHIBITOR DBREF 1K8Q A 1 377 UNP P80035 LIPG_CANFA 20 396 DBREF 1K8Q B 1 377 UNP P80035 LIPG_CANFA 20 396 SEQADV 1K8Q ALA A 1 UNP P80035 LEU 20 CONFLICT SEQADV 1K8Q ILE A 192 UNP P80035 LEU 211 CONFLICT SEQADV 1K8Q ALA B 1 UNP P80035 LEU 20 CONFLICT SEQADV 1K8Q ILE B 192 UNP P80035 LEU 211 CONFLICT SEQRES 1 A 377 ALA PHE GLY LYS LEU HIS PRO THR ASN PRO GLU VAL THR SEQRES 2 A 377 MET ASN ILE SER GLN MET ILE THR TYR TRP GLY TYR PRO SEQRES 3 A 377 ALA GLU GLU TYR GLU VAL VAL THR GLU ASP GLY TYR ILE SEQRES 4 A 377 LEU GLY ILE ASP ARG ILE PRO TYR GLY ARG LYS ASN SER SEQRES 5 A 377 GLU ASN ILE GLY ARG ARG PRO VAL ALA PHE LEU GLN HIS SEQRES 6 A 377 GLY LEU LEU ALA SER ALA THR ASN TRP ILE SER ASN LEU SEQRES 7 A 377 PRO ASN ASN SER LEU ALA PHE ILE LEU ALA ASP ALA GLY SEQRES 8 A 377 TYR ASP VAL TRP LEU GLY ASN SER ARG GLY ASN THR TRP SEQRES 9 A 377 ALA ARG ARG ASN LEU TYR TYR SER PRO ASP SER VAL GLU SEQRES 10 A 377 PHE TRP ALA PHE SER PHE ASP GLU MET ALA LYS TYR ASP SEQRES 11 A 377 LEU PRO ALA THR ILE ASP PHE ILE LEU LYS LYS THR GLY SEQRES 12 A 377 GLN ASP LYS LEU HIS TYR VAL GLY HIS SER GLN GLY THR SEQRES 13 A 377 THR ILE GLY PHE ILE ALA PHE SER THR ASN PRO LYS LEU SEQRES 14 A 377 ALA LYS ARG ILE LYS THR PHE TYR ALA LEU ALA PRO VAL SEQRES 15 A 377 ALA THR VAL LYS TYR THR GLU THR LEU ILE ASN LYS LEU SEQRES 16 A 377 MET LEU VAL PRO SER PHE LEU PHE LYS LEU ILE PHE GLY SEQRES 17 A 377 ASN LYS ILE PHE TYR PRO HIS HIS PHE PHE ASP GLN PHE SEQRES 18 A 377 LEU ALA THR GLU VAL CYS SER ARG GLU THR VAL ASP LEU SEQRES 19 A 377 LEU CYS SER ASN ALA LEU PHE ILE ILE CYS GLY PHE ASP SEQRES 20 A 377 THR MET ASN LEU ASN MET SER ARG LEU ASP VAL TYR LEU SEQRES 21 A 377 SER HIS ASN PRO ALA GLY THR SER VAL GLN ASN VAL LEU SEQRES 22 A 377 HIS TRP SER GLN ALA VAL LYS SER GLY LYS PHE GLN ALA SEQRES 23 A 377 PHE ASP TRP GLY SER PRO VAL GLN ASN MET MET HIS TYR SEQRES 24 A 377 HIS GLN SER MET PRO PRO TYR TYR ASN LEU THR ASP MET SEQRES 25 A 377 HIS VAL PRO ILE ALA VAL TRP ASN GLY GLY ASN ASP LEU SEQRES 26 A 377 LEU ALA ASP PRO HIS ASP VAL ASP LEU LEU LEU SER LYS SEQRES 27 A 377 LEU PRO ASN LEU ILE TYR HIS ARG LYS ILE PRO PRO TYR SEQRES 28 A 377 ASN HIS LEU ASP PHE ILE TRP ALA MET ASP ALA PRO GLN SEQRES 29 A 377 ALA VAL TYR ASN GLU ILE VAL SER MET MET GLY THR ASP SEQRES 1 B 377 ALA PHE GLY LYS LEU HIS PRO THR ASN PRO GLU VAL THR SEQRES 2 B 377 MET ASN ILE SER GLN MET ILE THR TYR TRP GLY TYR PRO SEQRES 3 B 377 ALA GLU GLU TYR GLU VAL VAL THR GLU ASP GLY TYR ILE SEQRES 4 B 377 LEU GLY ILE ASP ARG ILE PRO TYR GLY ARG LYS ASN SER SEQRES 5 B 377 GLU ASN ILE GLY ARG ARG PRO VAL ALA PHE LEU GLN HIS SEQRES 6 B 377 GLY LEU LEU ALA SER ALA THR ASN TRP ILE SER ASN LEU SEQRES 7 B 377 PRO ASN ASN SER LEU ALA PHE ILE LEU ALA ASP ALA GLY SEQRES 8 B 377 TYR ASP VAL TRP LEU GLY ASN SER ARG GLY ASN THR TRP SEQRES 9 B 377 ALA ARG ARG ASN LEU TYR TYR SER PRO ASP SER VAL GLU SEQRES 10 B 377 PHE TRP ALA PHE SER PHE ASP GLU MET ALA LYS TYR ASP SEQRES 11 B 377 LEU PRO ALA THR ILE ASP PHE ILE LEU LYS LYS THR GLY SEQRES 12 B 377 GLN ASP LYS LEU HIS TYR VAL GLY HIS SER GLN GLY THR SEQRES 13 B 377 THR ILE GLY PHE ILE ALA PHE SER THR ASN PRO LYS LEU SEQRES 14 B 377 ALA LYS ARG ILE LYS THR PHE TYR ALA LEU ALA PRO VAL SEQRES 15 B 377 ALA THR VAL LYS TYR THR GLU THR LEU ILE ASN LYS LEU SEQRES 16 B 377 MET LEU VAL PRO SER PHE LEU PHE LYS LEU ILE PHE GLY SEQRES 17 B 377 ASN LYS ILE PHE TYR PRO HIS HIS PHE PHE ASP GLN PHE SEQRES 18 B 377 LEU ALA THR GLU VAL CYS SER ARG GLU THR VAL ASP LEU SEQRES 19 B 377 LEU CYS SER ASN ALA LEU PHE ILE ILE CYS GLY PHE ASP SEQRES 20 B 377 THR MET ASN LEU ASN MET SER ARG LEU ASP VAL TYR LEU SEQRES 21 B 377 SER HIS ASN PRO ALA GLY THR SER VAL GLN ASN VAL LEU SEQRES 22 B 377 HIS TRP SER GLN ALA VAL LYS SER GLY LYS PHE GLN ALA SEQRES 23 B 377 PHE ASP TRP GLY SER PRO VAL GLN ASN MET MET HIS TYR SEQRES 24 B 377 HIS GLN SER MET PRO PRO TYR TYR ASN LEU THR ASP MET SEQRES 25 B 377 HIS VAL PRO ILE ALA VAL TRP ASN GLY GLY ASN ASP LEU SEQRES 26 B 377 LEU ALA ASP PRO HIS ASP VAL ASP LEU LEU LEU SER LYS SEQRES 27 B 377 LEU PRO ASN LEU ILE TYR HIS ARG LYS ILE PRO PRO TYR SEQRES 28 B 377 ASN HIS LEU ASP PHE ILE TRP ALA MET ASP ALA PRO GLN SEQRES 29 B 377 ALA VAL TYR ASN GLU ILE VAL SER MET MET GLY THR ASP MODRES 1K8Q ASN A 15 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN A 80 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN A 252 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN A 308 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN B 15 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN B 80 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN B 252 ASN GLYCOSYLATION SITE MODRES 1K8Q ASN B 308 ASN GLYCOSYLATION SITE HET NAG A1001 14 HET NAG A1002 14 HET NAG A1003 14 HET NAG A1005 14 HET BOG A1006 20 HET C11 A2001 18 HET NAG B1001 14 HET NAG B1002 14 HET NAG B1003 14 HET NAG B1005 14 HET BOG B2002 20 HET C11 B2001 18 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM C11 UNDECYL-PHOSPHINIC ACID BUTYL ESTER HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 7 BOG 2(C14 H28 O6) FORMUL 8 C11 2(C15 H33 O2 P) FORMUL 15 HOH *382(H2 O) HELIX 1 1 ASN A 9 MET A 14 5 6 HELIX 2 2 ASN A 15 TRP A 23 1 9 HELIX 3 3 SER A 70 ILE A 75 5 6 HELIX 4 4 SER A 82 ALA A 90 1 9 HELIX 5 5 SER A 122 TYR A 129 1 8 HELIX 6 6 TYR A 129 GLY A 143 1 15 HELIX 7 7 SER A 153 ASN A 166 1 14 HELIX 8 8 ASN A 166 LYS A 171 1 6 HELIX 9 9 THR A 190 LEU A 197 5 8 HELIX 10 10 PRO A 199 PHE A 207 1 9 HELIX 11 11 HIS A 216 VAL A 226 1 11 HELIX 12 12 VAL A 232 GLY A 245 1 14 HELIX 13 13 ASP A 247 LEU A 251 5 5 HELIX 14 14 ASN A 252 SER A 254 5 3 HELIX 15 15 ARG A 255 SER A 261 1 7 HELIX 16 16 VAL A 269 GLY A 282 1 14 HELIX 17 17 SER A 291 HIS A 300 1 10 HELIX 18 18 ASN A 308 MET A 312 5 5 HELIX 19 19 ASP A 328 SER A 337 1 10 HELIX 20 20 LEU A 354 ALA A 359 1 6 HELIX 21 21 ASP A 361 VAL A 366 1 6 HELIX 22 22 VAL A 366 THR A 376 1 11 HELIX 23 23 ASN B 9 MET B 14 5 6 HELIX 24 24 ASN B 15 TRP B 23 1 9 HELIX 25 25 SER B 70 ILE B 75 5 6 HELIX 26 26 SER B 82 ALA B 90 1 9 HELIX 27 27 SER B 122 TYR B 129 1 8 HELIX 28 28 TYR B 129 GLY B 143 1 15 HELIX 29 29 SER B 153 SER B 164 1 12 HELIX 30 30 ASN B 166 LYS B 171 1 6 HELIX 31 31 THR B 190 LEU B 197 5 8 HELIX 32 32 PRO B 199 PHE B 207 1 9 HELIX 33 33 HIS B 216 VAL B 226 1 11 HELIX 34 34 VAL B 232 GLY B 245 1 14 HELIX 35 35 ASP B 247 LEU B 251 5 5 HELIX 36 36 ASN B 252 SER B 254 5 3 HELIX 37 37 ARG B 255 SER B 261 1 7 HELIX 38 38 VAL B 269 GLY B 282 1 14 HELIX 39 39 SER B 291 HIS B 300 1 10 HELIX 40 40 ASN B 308 MET B 312 5 5 HELIX 41 41 ASP B 328 SER B 337 1 10 HELIX 42 42 LEU B 354 ALA B 359 1 6 HELIX 43 43 ASP B 361 VAL B 366 1 6 HELIX 44 44 VAL B 366 THR B 376 1 11 SHEET 1 A 8 GLU A 28 VAL A 33 0 SHEET 2 A 8 TYR A 38 ILE A 45 -1 O LEU A 40 N VAL A 32 SHEET 3 A 8 ASP A 93 LEU A 96 -1 O LEU A 96 N ASP A 43 SHEET 4 A 8 VAL A 60 GLN A 64 1 N ALA A 61 O TRP A 95 SHEET 5 A 8 LEU A 147 HIS A 152 1 O HIS A 148 N PHE A 62 SHEET 6 A 8 ILE A 173 LEU A 179 1 O TYR A 177 N TYR A 149 SHEET 7 A 8 ILE A 316 GLY A 321 1 O ALA A 317 N PHE A 176 SHEET 8 A 8 LEU A 342 ILE A 348 1 O TYR A 344 N VAL A 318 SHEET 1 B 3 GLU A 28 VAL A 33 0 SHEET 2 B 3 TYR A 38 ILE A 45 -1 O LEU A 40 N VAL A 32 SHEET 3 B 3 ARG A 107 ASN A 108 -1 O ARG A 107 N ILE A 39 SHEET 1 C 2 ILE A 211 PHE A 212 0 SHEET 2 C 2 THR A 267 SER A 268 -1 O THR A 267 N PHE A 212 SHEET 1 D 8 GLU B 28 VAL B 33 0 SHEET 2 D 8 TYR B 38 ILE B 45 -1 O LEU B 40 N VAL B 32 SHEET 3 D 8 ASP B 93 LEU B 96 -1 O LEU B 96 N ASP B 43 SHEET 4 D 8 VAL B 60 GLN B 64 1 N ALA B 61 O TRP B 95 SHEET 5 D 8 LEU B 147 HIS B 152 1 O VAL B 150 N GLN B 64 SHEET 6 D 8 ILE B 173 LEU B 179 1 O TYR B 177 N TYR B 149 SHEET 7 D 8 ILE B 316 GLY B 321 1 O ALA B 317 N PHE B 176 SHEET 8 D 8 LEU B 342 ILE B 348 1 O ILE B 343 N ILE B 316 SHEET 1 E 3 GLU B 28 VAL B 33 0 SHEET 2 E 3 TYR B 38 ILE B 45 -1 O LEU B 40 N VAL B 32 SHEET 3 E 3 ARG B 107 ASN B 108 -1 O ARG B 107 N ILE B 39 SHEET 1 F 2 ILE B 211 PHE B 212 0 SHEET 2 F 2 THR B 267 SER B 268 -1 O THR B 267 N PHE B 212 SSBOND 1 CYS A 227 CYS A 236 1555 1555 2.02 SSBOND 2 CYS B 227 CYS B 236 1555 1555 2.03 LINK ND2 ASN A 15 C1 NAG A1001 1555 1555 1.45 LINK ND2 ASN A 80 C1 NAG A1002 1555 1555 1.46 LINK OG SER A 153 P C11 A2001 1555 1555 1.60 LINK ND2 ASN A 252 C1 NAG A1003 1555 1555 1.45 LINK ND2 ASN A 308 C1 NAG A1005 1555 1555 1.45 LINK ND2 ASN B 15 C1 NAG B1001 1555 1555 1.46 LINK ND2 ASN B 80 C1 NAG B1002 1555 1555 1.45 LINK OG SER B 153 P C11 B2001 1555 1555 1.58 LINK ND2 ASN B 252 C1 NAG B1003 1555 1555 1.46 LINK ND2 ASN B 308 C1 NAG B1005 1555 1555 1.46 CISPEP 1 ASN A 263 PRO A 264 0 -0.21 CISPEP 2 ASN B 263 PRO B 264 0 0.66 CRYST1 61.209 164.498 177.156 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016337 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006079 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005645 0.00000